Gyre Therapeutics Ownership | Who Owns Gyre Therapeutics?

Gyre Therapeutics Ownership Summary

Gyre Therapeutics is owned by 3.74% institutional investors, 86.33% insiders, and 9.93% retail investors. Vanguard group is the largest institutional shareholder, holding 1.35% of GYRE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.74% of its assets in Gyre Therapeutics shares.

GYRE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Gyre Therapeutics	3.74%	86.33%	9.93%
Sector	Healthcare Stocks	35.75%	11.89%	52.37%
Industry	Biotech Stocks	36.05%	11.82%	52.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	1.20M	1.35%	$8.48M
Blackrock funding, inc. /de	758.63K	0.83%	$5.29M
Geode capital management	431.41K	0.47%	$3.01M
State street	216.33K	0.24%	$1.51M
Sbi securities	170.84K	0.19%	$1.19M
Charles schwab investment management	165.24K	0.18%	$1.15M
Vanguard fiduciary trust	137.68K	0.15%	$959.64K
Northern trust	133.84K	0.15%	$932.87K
Goldman sachs group	73.12K	0.08%	$509.66K
Bank of new york mellon	43.14K	0.05%	$300.71K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sbi securities	170.84K	0.03%	$1.19M
Tower research capital llc (trc)	5.76K	0.00%	$40.17K
Brevan howard capital management lp	13.81K	0.00%	$96.24K
Activest wealth management	533.00	0.00%	$3.71K
Strs ohio	21.10K	0.00%	$147.07K
State of alaska, department of revenue	5.22K	0.00%	$36.00K
Geode capital management	431.41K	0.00%	$3.01M
Charles schwab investment management	165.24K	0.00%	$1.15M
Eversource wealth advisors	163.00	0.00%	$4.99K
Vanguard fiduciary trust	137.68K	0.00%	$959.64K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard fiduciary trust	137.68K	0.00%	137.68K
Vanguard group	1.20M	0.00%	51.03K
Goldman sachs group	73.12K	0.00%	42.01K
Blackrock funding, inc. /de	758.63K	0.00%	38.34K
Dimensional fund advisors lp	25.27K	-	14.37K

Top Sellers

Holder	Shares	% Assets	Change
Morgan stanley	8.64K	-	-45.86K
State of wisconsin investment board	-	-	-24.80K
Nuveen	-	-	-17.59K
Barclays	2.30K	-	-16.23K
Advantage alpha capital partners lp	-	-	-13.66K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	137.68K	0.00%	137.68K	$959.64K
Brevan howard capital management lp	13.81K	0.00%	13.81K	$96.24K
Vanguard global advisers	9.98K	-	9.98K	$69.58K
Allworth financial lp	721.00	-	721.00	$5.03K
Eversource wealth advisors	163.00	0.00%	163.00	$4.99K

Sold Out

Holder	Change
True wealth design	-6.00
Massmutual trust co fsb/adv	-12.00
Rise advisors	-54.00
Srs capital advisors	-57.00
Federation des caisses desjardins du quebec	-75.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	54	25.58%	3,407,279	1.87%	3	26.54%	31	24.00%	11	37.50%
Dec 31, 2025	10	-78.26%	1,417,139	-54.22%	1	13.18%	3	-87.50%	3	-78.57%
Sep 30, 2025	15	-65.12%	1,514,519	-54.84%	1	12.00%	6	-80.65%	5	-28.57%
Jun 30, 2025	46	4.55%	3,409,780	30.67%	3	41.97%	34	47.83%	7	-50.00%
Mar 31, 2025	44	15.79%	2,609,380	57.10%	3	80.28%	23	15.00%	14	55.56%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	718.35K	0.74%	-9.15K
iShares Russell 2000 ETF	274.98K	0.28%	2.55K
Vanguard Institutional Extnd Mkt Idx Tr	233.12K	0.24%	-
Fidelity Small Cap Index	115.93K	0.12%	1.60K
Fidelity Extended Market Index	111.24K	0.11%	-406.00
Schwab US Small-Cap ETF™	99.89K	0.10%	63.00
iShares Russell 2000 Growth ETF	94.44K	0.10%	-615.00
Russell 2000 Equity Index Fund B	86.97K	0.09%	49.12K
Fidelity Nasdaq Composite Index	60.24K	0.06%	-
Vanguard Russell 2000 ETF	59.42K	0.06%	1.23K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 10, 2026	Ye Weiguo	Chief Operating Officer	Sell	$31.20K
Jun 09, 2026	Ye Weiguo	Chief Operating Officer	Sell	$18.45K
Jun 18, 2026	Ye Weiguo	Chief Operating Officer	Sell	$19.05K
Jun 11, 2026	Ye Weiguo	Chief Operating Officer	Sell	$17.28K
Jun 09, 2026	Ye Weiguo	Chief Operating Officer	Sell	$89.03K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	13
2026 Q1	-	-
2025 Q3	-	-
2025 Q2	-	12
2025 Q1	-	59

GYRE Ownership FAQ

Who Owns Gyre Therapeutics?

Gyre Therapeutics shareholders are primarily institutional investors at 3.74%, followed by 86.33% insiders and 9.93% retail investors. The average institutional ownership in Gyre Therapeutics's industry, Biotech Stocks , is 36.05%, which Gyre Therapeutics falls below.

Who owns the most shares of Gyre Therapeutics?

Gyre Therapeutics’s largest shareholders are Vanguard group (1.2M shares, 1.35%), Blackrock funding, inc. /de (758.63K shares, 0.83%), and Geode capital management (431.41K shares, 0.47%). Together, they hold 2.65% of Gyre Therapeutics’s total shares outstanding.

Does Blackrock own Gyre Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Gyre Therapeutics.

Who is Gyre Therapeutics’s biggest shareholder by percentage of total assets invested?

Sbi securities is Gyre Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 170.84K Gyre Therapeutics shares, valued at 1.19M$.

Who is the top mutual fund holder of Gyre Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Gyre Therapeutics shares, with 0.74% of its total shares outstanding invested in 718.35K Gyre Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools